Eikon Therapeutics
EIKN
NASDAQ
IPO2026
about EIKN
Eikon Therapeutics is a biotechnology company focused on developing innovative gene-editing therapies using CRISPR-Cas9 technology to address challenges in oncology and rare diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $14.82 | $16.16 | $14.50 | $812.46M | 307.67K |